Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease

Blood. 2001 Nov 15;98(10):3173-4. doi: 10.1182/blood.v98.10.3173.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Combined Modality Therapy
  • Culicidae / immunology*
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Epstein-Barr Virus Infections / complications*
  • Epstein-Barr Virus Infections / immunology
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Herpesvirus 4, Human / physiology
  • Humans
  • Hypersensitivity / complications*
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Insect Bites and Stings / immunology*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / pathology*
  • Killer Cells, Natural / virology
  • Lymphoproliferative Disorders / complications*
  • Lymphoproliferative Disorders / immunology
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Receptors, Antigen, T-Cell, gamma-delta / analysis
  • Remission Induction
  • Skin / immunology
  • Skin / pathology
  • Skin / virology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology*
  • T-Lymphocyte Subsets / virology
  • Virus Activation

Substances

  • Immunosuppressive Agents
  • Receptors, Antigen, T-Cell, gamma-delta
  • Cyclosporine